HIGHER Corporation, a pioneering medical device startup, has recently been honored as a 'Baby Unicorn' by the Ministry of SMEs and Startups, alongside receiving the 'First Penguin' designation from the Korea Credit Guarantee Fund. These accolades not only validate the company's innovative approach to medical technology but also spotlight its significant potential to emerge as a global leader in the aesthetic medical device sector.
The 'Baby Unicorn' program is instrumental in fostering startups with high growth potential, offering them the necessary support to scale internationally. HIGHER Corporation's inclusion in this program is a testament to its groundbreaking HILO WAVE® technology, a collagen booster that stands out for its ability to enhance skin elasticity and hydration through natural regeneration processes. This technology, approved as a Class 4 medical device in Korea, represents a leap forward in non-invasive aesthetic treatments, offering both immediate and long-term benefits.
With secured contracts in Southeast Asia and ongoing negotiations in Brazil and China, HIGHER Corporation is rapidly expanding its global footprint. The company's strategic moves, including pursuing CE MDR certification for European market entry, highlight its ambition to dominate the international aesthetic medical device market. The support from the 'Baby Unicorn' program, including financial aid and market development opportunities, will undoubtedly accelerate these efforts.
The recognition of HIGHER Corporation as a 'Baby Unicorn' is not just a milestone for the company but also a significant development for the Korean startup ecosystem. It reflects the country's growing influence in the global medical technology arena and the potential of its startups to drive innovation and economic growth. For consumers and medical professionals worldwide, HIGHER Corporation's advancements promise safer, more effective solutions for skin care and rejuvenation, marking a new era in aesthetic medicine.
